> ## Content Index > Fetch the complete content index at: https://www.frenchtechjournal.com/llms.txt > Use this file to discover other available public pages before exploring further. # The Big Deals 💣 : Electra, Scalinx, Enyo Pharma, Nabla & more - URL: https://www.frenchtechjournal.com/the-big-deals-electra-scalinx-nabla/ - Published: 2024-01-16T23:10:47.000Z - Updated: 2024-01-16T23:10:47.000Z - Description: Electra lights a fuse on the new year with a €304m round to build out its EV charting stations. - Author: Helen O'Reilly-Durand - Tags: Funding News ## 🔥 The Mega deal: Electra ![](https://www.frenchtechjournal.com/content/images/2024/01/electra-logo.png) **What**: A Paris-based manufacturer of fast-charging EV stations. **Why:** To remove all barriers to the adoption of electric cars by deploying the most efficient network of fast-charging stations in Europeand making charging EVs as easy as filling up the petrol tank. **Funding**: €304 million **Who:** Co-founders, [Aurélien de Meaux (CEO),](https://www.linkedin.com/in/ademeaux/?ref=frenchtechjournal.com) [Augustin Derville (CDO)](https://www.linkedin.com/in/augustin-derville-948a53105/?ref=frenchtechjournal.com), [Julien Belliato (COO)](https://www.linkedin.com/in/julien-belliato-3a35391b/?ref=frenchtechjournal.com) **Investors:** PGGM (Dutch pension fund), Bpifrance, Eurazeo Infrastructure, Serena, Rive Private Investment, 574 Invest (investment branch of the national rail company, SNCF). **What's next:** This staggering Series B round will go to consolidating Electra's position by deploying 2,200 stations across the 8 European countries in which they are present— representing 15k charging points — by 2030. ![](https://www.frenchtechjournal.com/content/images/2024/01/Scalinx-logo.png) **What:** Scalinx, a manufacturer of signal conversion and processing chips for antennas. **Why:** Toenable analog-to-digital and digital-to-analog conversion of wide-band signals with low power consumption for wired and wireless communications, test and measurement equipment**,** and radars **Funding**: €34 million **Who:** Founder & CEO, [Hussein Fakhoury](https://www.linkedin.com/in/hussein-fakhoury-399a451b/?originalSubdomain=fr&ref=frenchtechjournal.com) **Investors:** Thales, Go Capital, Bpifrance, WaterStart Capital, Normandie Participations, BNP Paribas Développement, Unexo **What's next:** This new round of funding will enable the company to develop cutting-edge system-on-chip (SoC) solutions and expand its customer base. ![](https://www.frenchtechjournal.com/content/images/2024/01/Vulkam-logo.png) **What:** Vulkam,a Deeptech company that develops amorphous metals (metallic glasses) known as "Vulkalloys®". **Why:** To create unparalleled micro-mechanical parts, for use in industrial and medical equipment. **Funding:** €34 million (of which €14 m equity) ‌‌ **Who:** Founder & President, [Sébastien Gravier](https://www.linkedin.com/in/sebastien-gravier-3737386b/?ref=frenchtechjournal.com) ‌**Investors**: SEB industrial group & Bpifrance ‌‌ ‌**What's Next:** Vulkam will use the fresh funds to finance the 2025 operational launch of its first factory located in Isère and dedicated to the production of its new metals. ![](https://www.frenchtechjournal.com/content/images/2024/01/Enyo-pharma-logo.jpeg) **What: Enyo Pharma** is a biotech specializing in producing trial medicines for rare kidney diseases. **Why:** To enhance the quality of life and prevent end-stage renal failure and dialysis in patients with kidney diseases. **Funding:** €27 million ‌‌ **Who:** Co-founders [Jacky Vonderscher](https://www.linkedin.com/in/jacky-vonderscher-4823311/?ref=frenchtechjournal.com) , [Laurène Meyniel-Schicklin](https://www.linkedin.com/in/laurene-meyniel-schicklin/?ref=frenchtechjournal.com), [Dr Benoît de Chassey](https://www.linkedin.com/in/benoit-de-chassey-95968378/?ref=frenchtechjournal.com),[ Pr Patrice André](https://www.linkedin.com/in/patrice-andr%C3%A9-aa367259/?ref=frenchtechjournal.com), [Dr Vincent Lotteau](https://www.linkedin.com/in/lotteau-vincent-10435411/?ref=frenchtechjournal.com), Dr [Jean-Jacques Garaud](https://www.linkedin.com/in/jean-jacques-garaud-97055a54/?ref=frenchtechjournal.com) ‌**Investors**: OrbiMed, Morningside Ventures, AndEra Partners, Bpifrance InnoBio, & Bpifrance Large Ventures ‌‌ ‌**What's Next:** The raise will finance a new clinical study of their trial medicine, "Vonafexor", to be tested on Alport syndrome patients during the first half of this year and continue investments in the R&D of Vonafexor for use on other kidney diseases, such as autosomal dominant polycystic kidney disease (PKRAD). ![](https://www.frenchtechjournal.com/content/images/2024/01/nabla-logo.jpeg) **What: Nabla**, an AI assistant for doctors and healthcare professionals **Why:** To allow healthcare professionals with their admin by generating written clinical notes and reports, across multiple medical sectors in seconds **Funding:** €22 million **Who:** Co-Founders [Martin Raison](https://www.linkedin.com/in/martinraison/?ref=frenchtechjournal.com), [Delphine Groll](https://www.linkedin.com/in/delphine-groll-2aa68638/?ref=frenchtechjournal.com), [Alexandre Lebrun ](https://www.linkedin.com/in/alexandrelebrun/?ref=frenchtechjournal.com) **Investors:** Cathay Innovation, Zebox Ventures **What's next:** The raise will enable Nabla to boost expansion across U.S. healthcare systems and continue transforming the way providers deliver care. ![](https://www.frenchtechjournal.com/content/images/2024/01/hiboo-logo.png) **What:** Hiboo, a construction tech SaaS platform. **Why:** To help manufacturers optimize the use and energy efficiency of their site machinery/industrial equipment by making operations more efficient and environmentally responsible. **Funding:** €9.3 million **Who:** Co-Founders [Clément Bénard](https://www.linkedin.com/in/cl%C3%A9ment-b%C3%A9nard/?ref=frenchtechjournal.com) & [Marie de Raismes - Baron](https://www.linkedin.com/in/mariederaismes/?originalSubdomain=fr&ref=frenchtechjournal.com) **Investors:** Emerald Technology Ventures, Isai Build Venture, Future Industry Ventures, Ring Capital, Citizen Capital **What's next:** The new funding will enable Hiboo to accelerate the development of new products, strengthen its teams, and fuel its international expansion, notably in Europe and the United States. ![](https://www.frenchtechjournal.com/content/images/2024/01/Womed-logo.png) **What:** Womed, a biotech specializing in innovative and safe treatments. **Why:** To free women from complex uterine pathologies such as infertility, uterine bleeding, and endometriosis. **Funding:** €6 million **Who:** Co-Founders, [Gonzague Issenmann](https://www.linkedin.com/in/gonzague/?ref=frenchtechjournal.com), Dr. [Stéphanie Huberlant](https://www.linkedin.com/in/st%C3%A9phanie-huberlant-balas-487b93bb/?ref=frenchtechjournal.com), [Prof. Xavier Garric](https://www.linkedin.com/in/xaviergarric/%60?ref=frenchtechjournal.com)\`\` **Investors:** Irdi & Family-offices **What's next:** Womed will use the fundsto launch the commercialization of its intrauterine device against infertility.